TY - JOUR
T1 - Cytochrome P450-derived arachidonic acid metabolism in the rat kidney
T2 - Characterization of selective inhibitors
AU - Wang, Mong Heng
AU - Brand-Schieber, Elimor
AU - Zand, Barbara A.
AU - Nguyen, Xuandai
AU - Falck, J R
AU - Balu, Narayanan
AU - Schwartzman, Michal Laniado
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1998/3
Y1 - 1998/3
N2 - We characterized the inhibitory activity of several acetylenic and olefinic compounds on cytochrome P450 (CYP)-derived arachidonic acid ω- hydroxylation and epoxidation using rat renal cortical microsomes and recombinant CYP proteins. Among the acetylenic compounds, 6-(2- propargyloxyphenyl-)hexanoic acid (PPOH) and N-methylsulfonyl-6-(2- propargyloxyphenyl)hexanamide were found to be potent and selective inhibitors of microsomal epoxidation with IC50 values of 9 and 13 μM, respectively. On the other hand, 17-octadecynoic acid inhibited both ω- hydroxylation and epoxidation of arachidonic acid with IC50 values of 7 and 5 μM, respectively. The olefinic compounds N-methylsulfonyl-12,12- dibromododec-11-enamide (DDMS) and 12,12-dibromododec-11-enoic acid (DBDD) exhibited a high degree of selectivity inhibiting microsomal ω-hydroxylation with an IC50 value of 2 μM, whereas the IC50 values for epoxidation were 60 and 51 μM for DDMS and DBDD, respectively. Studies using recombinant rat CYP4A isoforms showed that PPOH caused a concentration-dependent inhibition of ω-hydroxylation and 11,12-epoxidation by CYP4A3 or CYP4A2 but had no effect on CYP4A1-catalyzed ω-hydroxylase activity. On the other hand, DDMS inhibited both CYP4A1- and CYP4A3- or CYP4A2-catalyzed arachidonic acid oxidations. Inhibition of microsomal activity by PPOH, but not DDMS, was time- and NADPH-dependent, a result characteristic of a mechanism-based irreversible inhibitor. These studies provide information useful for evaluating the role of the CYP-derived arachidonic acid metabolites in the regulation of renal function and blood pressure.
AB - We characterized the inhibitory activity of several acetylenic and olefinic compounds on cytochrome P450 (CYP)-derived arachidonic acid ω- hydroxylation and epoxidation using rat renal cortical microsomes and recombinant CYP proteins. Among the acetylenic compounds, 6-(2- propargyloxyphenyl-)hexanoic acid (PPOH) and N-methylsulfonyl-6-(2- propargyloxyphenyl)hexanamide were found to be potent and selective inhibitors of microsomal epoxidation with IC50 values of 9 and 13 μM, respectively. On the other hand, 17-octadecynoic acid inhibited both ω- hydroxylation and epoxidation of arachidonic acid with IC50 values of 7 and 5 μM, respectively. The olefinic compounds N-methylsulfonyl-12,12- dibromododec-11-enamide (DDMS) and 12,12-dibromododec-11-enoic acid (DBDD) exhibited a high degree of selectivity inhibiting microsomal ω-hydroxylation with an IC50 value of 2 μM, whereas the IC50 values for epoxidation were 60 and 51 μM for DDMS and DBDD, respectively. Studies using recombinant rat CYP4A isoforms showed that PPOH caused a concentration-dependent inhibition of ω-hydroxylation and 11,12-epoxidation by CYP4A3 or CYP4A2 but had no effect on CYP4A1-catalyzed ω-hydroxylase activity. On the other hand, DDMS inhibited both CYP4A1- and CYP4A3- or CYP4A2-catalyzed arachidonic acid oxidations. Inhibition of microsomal activity by PPOH, but not DDMS, was time- and NADPH-dependent, a result characteristic of a mechanism-based irreversible inhibitor. These studies provide information useful for evaluating the role of the CYP-derived arachidonic acid metabolites in the regulation of renal function and blood pressure.
UR - http://www.scopus.com/inward/record.url?scp=0031887331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031887331&partnerID=8YFLogxK
M3 - Article
C2 - 9495856
AN - SCOPUS:0031887331
SN - 0022-3565
VL - 284
SP - 966
EP - 973
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -